EVM 101
Alternative Names: EVM-101Latest Information Update: 27 Oct 2022
At a glance
- Originator Enveric Biosciences; University of Calgary
- Developer Enveric Biosciences
- Class Behavioural disorder therapies; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Psychotic disorders